Bringing the fundamentals into focus…
Back to West Pharmaceutical Services, Inc.
How West Pharmaceutical Services, Inc. stacks up
WST · against 88 other Healthcare companies of similar size
Valuation
48/ 100
Below the middle of the pack.
Ranked #64 of 89 · scores higher than 27% of peers
Bars: peers in each 10-point band of the valuation score17 peers with a valuation score of 40–49, including WST · Click a bar to see the companies
Why valuation scores 48?
Weighted metrics compared with all Healthcare companies.Its metrics sit close to the Healthcare norm.
- EBITDA yield is close to the peer norm. EBITDA yield: 3.0% vs peer median 4.0%
- Earnings yield is close to the peer norm. Earnings yield: 2.0% vs peer median 1.5%
- Free cash flow yield is close to the peer norm. Free cash flow yield: 1.5% vs peer median 0.0%
Metric by metric
Position: dot = WST, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | WST | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 86 reported | 1.9% | 2.8% | 31% | 30% | |
| EBITDA yieldHigher is better · 89 reported | 3.2% | 5.0% | 26% | 50% | |
| Free cash flow yieldHigher is better · 59 reported | 1.5% | 3.6% | 16% | 20% | |
| Book yieldHigher is better · 82 reported | 10.4% | 19.5% | 25% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around WST| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 21.5B USD | 95 | 60 | |
| 2 | 4.61T JPY (≈$31.3B) | 93 | 76 | |
| 3 | 14.4B USD | 92 | 71 | |
| 4 | 2.57T JPY (≈$17.5B) | 88 | 62 | |
| 5 | 6.17T JPY (≈$42.0B) | 86 | 70 | |
| 60 | 52.9B USD | 49 | 57 | |
| 60 | 32.3B AUD (≈$21.3B) | 49 | 55 | |
| 60 | 15.8B EUR (≈$17.4B) | 49 | 47 | |
| 64 | 18.2B USD | 48 | 40 | |
| 64 | 28.6B USD | 48 | 60 | |
| 66 | 43.30T KRW (≈$31.2B) | 47 | 68 | |
| 66 | 54.9B USD | 47 | 59 | |
| 68 | 21.7B EUR (≈$23.9B) | 46 | 47 | |
| 68 | 40.2B USD | 46 | 73 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score